TRACON Pharmaceuticals In...
(TCON)
undefined
undefined%
At close: undefined
1.08
3254.04%
After-hours Jun 27, 2024, 07:53 PM EDT
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -3.59M | -29.14M | -28.67M | -16.77M | -22.67M | -34.96M | -19.10M | -27.01M | -24.41M | -6.81M | -7.71M | -4.93M |
| Depreciation & Amortization | - | 70.00K | -59.00K | -13.00K | 16.00K | 28.00K | 48.00K | 94.00K | 51.00K | 15.00K | 7.00K | 6.00K |
| Stock-Based Compensation | 1.97M | 2.04M | 1.77M | 1.03M | 1.62M | 2.67M | 3.19M | 3.08M | 2.09M | 271.00K | 275.00K | 58.00K |
| Other Working Capital | 630.00K | -6.00K | -138.00K | 299.00K | 542.00K | 62.00K | -450.00K | 383.00K | -69.00K | -1.70M | 604.00K | -269.00K |
| Other Non-Cash Items | 6.06M | 1.02M | -164.00K | 292.00K | 315.00K | -2.62M | 2.18M | -1.60M | -3.14M | 7.25M | 30.00K | 58.00K |
| Deferred Income Tax | - | - | -1K | -1K | -52.00K | -100.00K | 108.00K | 103.00K | 170.00K | 62.00K | 122.00K | -356.00K |
| Change in Working Capital | -761.00K | -239.00K | 4.54M | -1.58M | -2.88M | 4.20M | 326.00K | -1.82M | 6.08M | 971.00K | 604.00K | -269.00K |
| Operating Cash Flow | 3.68M | -26.24M | -22.57M | -17.04M | -23.65M | -30.78M | -13.24M | -27.15M | -19.16M | 1.76M | -6.67M | -5.43M |
| Capital Expenditures | - | -17.00K | -48.00K | -5.00K | - | - | -39.00K | -3.00K | -127.00K | -70.00K | -7.00K | -10.00K |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | -4.00M | -4.98M | -32.87M | -13.99M | -17.51M | -12.79M | - | - | - |
| Sales Maturities Of Investments | - | - | 4.00M | - | 19.00M | 24.00M | 17.70M | 19.58M | 2.00M | - | - | - |
| Other Investing Acitivies | - | - | 4.00M | -4.00M | 14.02M | -8.87M | 3.71M | 2.08M | -10.79M | - | - | - |
| Investing Cash Flow | - | -17.00K | 3.95M | -4.00M | 14.02M | -8.87M | 3.67M | 2.07M | -10.92M | -70.00K | -7.00K | -10.00K |
| Debt Repayment | -20.50M | 11.71M | -2.80M | -1.40M | -1.40M | -1.32M | -850.00K | -2.00M | 70.00K | 6.58M | 2.50M | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 45.00K | 95.00K | 149.00K | 2.00K | 12.00K | 185.00K | 35.00K | 178.00K | - | 25.65M | 3.99M | 3.97M |
| Financial Cash Flow | -12.54M | 19.68M | 10.56M | 36.76M | 906.00K | 35.32M | 3.33M | 19.41M | 36.45M | 31.04M | 6.49M | 3.97M |
| Net Cash Flow | -8.86M | -6.57M | -8.06M | 15.72M | -8.72M | -4.33M | -6.24M | -5.66M | 6.37M | 32.72M | -183.00K | -1.47M |
| Free Cash Flow | 3.68M | -26.26M | -22.62M | -17.05M | -23.65M | -30.78M | -13.28M | -27.15M | -19.29M | 1.69M | -6.68M | -5.44M |